Event recap: Healthcare claims, drug trial data help investors determine COVID-19 impact

Sondra Campanelli, Head of News and Marketing (London)

Neudata News
Post feature

Investors are using various sources of data to analyse the performance of healthcare companies, particularly as the race to develop better treatments and a vaccine for COVID-19 continues.